BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 20353535)

  • 1. Prostate-cancer screening in an Afro-Caribbean population: the Tobago Prostate Cancer Screening Study.
    Patrick A
    BJU Int; 2010 Mar; 105(6):745-6. PubMed ID: 20353535
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostate cancer risk is three-fold higher among men, aged 50-64, of African descent compared with men of Asian-Indian descent in Trinidad and Tobago.
    Bunker CH; Patrick AL; Maharaj G; Keenan HA; Ramnarine S; Belle A; Richard JR; Dhir R
    Ethn Dis; 2002; 12(4):S3-30-3. PubMed ID: 12477151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of screening-detected prostate cancer among Afro-Caribbeans: the Tobago Prostate Cancer Survey.
    Bunker CH; Patrick AL; Konety BR; Dhir R; Brufsky AM; Vivas CA; Becich MJ; Trump DL; Kuller LH
    Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):726-9. PubMed ID: 12163325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ELAC2 and prostate cancer risk in Afro-Caribbeans of Tobago.
    Shea PR; Ferrell RE; Patrick AL; Kuller LH; Bunker CH
    Hum Genet; 2002 Oct; 111(4-5):398-400. PubMed ID: 12384782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PSA screening and prostate cancer mortality.
    Perron L; Moore L; Bairati I; Bernard PM; Meyer F
    CMAJ; 2002 Mar; 166(5):586-91. PubMed ID: 11898936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Screening for prostatic cancer].
    Pushkar' DIu; Govorov AV; Bormotin AV
    Urologiia; 2003; (1):10-5. PubMed ID: 12621959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 15-year followup of a population based prostate cancer screening study.
    Kjellman A; Akre O; Norming U; Törnblom M; Gustafsson O
    J Urol; 2009 Apr; 181(4):1615-21; discussion 1621. PubMed ID: 19233435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rural residence and prostate cancer screening with prostate-specific antigen.
    Stamatiou K; Skolarikos A
    Rural Remote Health; 2009; 9(2):1227. PubMed ID: 19594290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate cancer mortality in relation to screening by prostate-specific antigen testing and digital rectal examination: a population-based study in middle-aged men.
    Agalliu I; Weiss NS; Lin DW; Stanford JL
    Cancer Causes Control; 2007 Nov; 18(9):931-7. PubMed ID: 17641982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer characteristics and survival in males of African Ancestry according to place of birth: data from Brooklyn-New York, Guyana, Tobago and Trinidad.
    Mutetwa B; Taioli E; Attong-Rogers A; Layne P; Roach V; Ragin C
    Prostate; 2010 Jul; 70(10):1102-9. PubMed ID: 20503395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for prostate cancer: updated experience from the Tyrol study.
    Horninger W; Berger A; Pelzer A; Klocker H; Oberaigner W; Schönitzer D; Severi G; Robertson C; Boyle P; Bartsch G
    Can J Urol; 2005 Feb; 12 Suppl 1():7-13; discussion 92-3. PubMed ID: 15780158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in breast cancer mortality in Trinidad and Tobago--a 35-year study.
    Naraynsingh V; Hariharan S; Dan D; Bhola S; Bhola S; Nagee K
    Cancer Epidemiol; 2010 Feb; 34(1):20-3. PubMed ID: 19963444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The case for prostate cancer screening.
    Andriole GL
    Semin Urol; 1993 May; 11(2):50-3. PubMed ID: 7689738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mass screening for prostate cancer at a local town--five-year results and screening system].
    Komeda Y; Suzuki R; Maeda Y; Okabe S; Kawamura J; Hioki T; Ohawa M
    Hinyokika Kiyo; 1994 Apr; 40(4):315-8. PubMed ID: 7514844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast, colon, and prostate screening in the adult population of Croatia: does rural origin matter?
    Polasek O; Kolcic I; Voncina L; Strnad M; Vuletic S; Kern J
    Rural Remote Health; 2007; 7(3):749. PubMed ID: 17900222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for prostate cancer.
    Ruffin MT
    J Fam Pract; 1999 Aug; 48(8):581-2. PubMed ID: 10496634
    [No Abstract]   [Full Text] [Related]  

  • 17. Prostate cancer mortality in screen and clinically detected prostate cancer: estimating the screening benefit.
    van Leeuwen PJ; Connolly D; Gavin A; Roobol MJ; Black A; Bangma CH; Schröder FH
    Eur J Cancer; 2010 Jan; 46(2):377-83. PubMed ID: 19804966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quebec prostate cancer mortality dropped in 1996.
    Meyer F; Moore L; Bairati I; Fradet Y
    Cancer Prev Control; 1998 Aug; 2(4):163-6. PubMed ID: 10093628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer and race.
    Brawley OW; Jani AB; Master V
    Curr Probl Cancer; 2007; 31(3):211-25. PubMed ID: 17543949
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prostate cancer screening and mortality in a European Community trial].
    Delgado-Rodríguez M
    Enferm Clin; 2010; 20(1):64-5. PubMed ID: 20149703
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.